SP
The startup develops bioassay technology that integrates clinical biomarker development, bioinformatics, and paper-based microfluidics to create assays for early detection of liver damage. This technology enables healthcare providers to quickly identify liver issues, reducing treatment costs and optimizing patient care.
Updated 3 months ago
Funding
$17.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops bioassay technology that integrates clinical biomarker development, bioinformatics, and paper-based microfluidics to create assays for early detection of liver damage. This technology enables healthcare providers to quickly identify liver issues, reducing treatment costs and optimizing patient care.